Optimizing Outcomes for HR+, HER2- Metastatic Breast Cancer
Released On
November 1, 2024
Expires On
October 28, 2025
Media Type
Internet
Completion Time
90 minutes
Specialty
Hematology-Oncology
Topic(s)
Breast Cancer
This activity is supported by an educational grant from AstraZeneca.
Credit Available
- Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
- Pharmacists — 1.5 ACPE CE Hours
- Nurses — 1.5 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of physicians, nurses, physician assistants, pharmacists, and other clinicians involved with caring for patients with HR+, HER2- metastatic breast cancer.
Program Overview
This program will cover evidence-based treatment options and treatment selection strategies, the management of treatment-related adverse events, and ways to optimize quality of life for patients with HR+, HER2- metastatic breast cancer.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Discuss evidence-based treatment for patients with HR+, HER2– metastatic breast cancer, including treatment selection strategies
- Outline evaluation and management for patients with potential treatment-related adverse events
- Describe practices that can improve quality of life and clinical outcomes in HR+, HER2– metastatic breast cancer
Faculty
Allison Butts, PharmD, BCOP
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
Assistant Adjunct Professor, UK College of Pharmacy
Acute Care Pharmacy Services
University of Kentucky Health Care
Lexington, KY
Pavani Chalasani, MD, MPH
Professor of Medicine
Director, Division of Hematology and Oncology
George Washington Cancer Center
George Washington University
Washington, DC
Claudia Franco, PA-C
Physician Assistant, Medical Oncology/Hematology
Inova Schar Cancer Institute
Fairfax, VA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians' Education Resource®, LLC and the Association of Cancer Care Centers (ACCC). Physicians' Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC (PER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC has approved this application-based activity for 1.50 ACPE CE hours. The Universal Activity Number for this activity is 0661-9999-24-002-H01-P. Eligibility for credits requires engagement with all online activities, completion of pre- and post-activity assessments with a minimum passing score of 70%, and submission of activity evaluation, NABP e-pid# and month/date of birth within 45 days of activity completion. No partial credits are given. This UAN expires October 28, 2026.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing (CBRN), Provider #16669, for 1.50 total Contact Hours. Eligibility for credits requires full attendance; no partial credits are given.
Disclosures of Conflicts of Interest
- Allison Butts, PharmD, BCOP
- Nothing to disclose
- Pavani Chalasani, MD, MPH
- Relationship: Grant funding for clinical trial: Pfizer
- Relationship: Institutional support for clinical trial: Stemline Therapeutics
- Relationship: Institutional support for clinical trial: Vaxiion Therapeutics
- Relationship: Institutional support for clinical trial: Personalis
- Relationship: Institutional support for clinical trial: Immutep
- Claudia Franco, PA-C
- Nothing to disclose
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Participate in the online activity (3 videos, pre-and-post activity assessments).
- Achieve a score of 70% or higher on the post-test.
- Submit the evaluation form.
Once you have completed the steps above, you can select to Claim Credit and download your certificate.
Pharmacists: Your participation will be uploaded to the CPE Monitor. Please note, you MUST provide your NABP (e-profile ID) number and date of birth in order to have your participation data uploaded.
Course Viewing Requirements
Supported Browsers (Desktop/Mobile)
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Off-Label Disclosure and Disclaimer
This CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician, nurse, or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC or ACCC.
Mention of tradenames in this presentation are being used to aid in understanding, not to endorse a specific product.
Contact Information
For CME questions please contact: [email protected].